Evaluation of FID 114657 in Sjogren's Syndrome Subjects
Not Applicable
Completed
- Conditions
- Sjogren's Syndrome
- Interventions
- Other: FID 114657 (ORB Preserved Ocular Emulsion)
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 50
- Registration Number
- NCT01079871
Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye Ointment
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Refresh PM OintmentOther: Lubricant eye drop FID 115958D
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT01076998
Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye Gel
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Lubricant eye drop FID 115958DOther: GenTeal Gel
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 25
- Registration Number
- NCT01077011
Visual Function After Implantation of AcrySof® Toric Lens
Phase 4
Terminated
- Conditions
- Cataract
- Interventions
- Device: AcrySof Toric Intraocular Lens
- First Posted Date
- 2010-02-24
- Last Posted Date
- 2012-09-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 56
- Registration Number
- NCT01074606
Safety and Efficacy of Moxidex Otic
Phase 3
Terminated
- Conditions
- Acute Otitis Media
- Interventions
- First Posted Date
- 2010-02-19
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 400
- Registration Number
- NCT01071902
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Compliance and Contamination in Soft Contact Lens Wearers
Completed
- Conditions
- Contact Lens Wear
- Interventions
- Device: OPTI-FREE RepleniSHDevice: Clear Care
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT01069237
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: ORB Ocular EmulsionOther: SootheXP Emollient (Lubricant) Eye Drops
- First Posted Date
- 2010-02-11
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT01066988
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Bioavailability of Nutrients Contained in Softgel Capsules vs Tablets
Phase 4
Completed
- Conditions
- Vision
- Interventions
- Dietary Supplement: ICAPS Eye Vitamin and Mineral Supplement - Softgel (full strength)Dietary Supplement: ICAPS Eye Vitamin and Mineral Supplement - Softgel (half strength)Dietary Supplement: ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets (full strength)
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 15
- Registration Number
- NCT01057966
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
ELAZOP Switching Study in Korea
Phase 4
Completed
- Conditions
- Open Angle Glaucoma
- Interventions
- Drug: Elazop (Azarga)
- First Posted Date
- 2010-01-25
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 96
- Registration Number
- NCT01055366
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Sungnam, Gyounggi, Korea, Republic of
🇰🇷Youngnam Univ. Hospital, Daegu, Korea, Republic of
Evaluation of the Repeated Usage of Systane Ultra Eyedrop
Phase 4
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Systane UltraOther: Optive lubricant Eye Drops
- First Posted Date
- 2010-01-20
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 57
- Registration Number
- NCT01051804
© Copyright 2025. All Rights Reserved by MedPath